JanOne Inc (JAN) USD0.001
JanOne Inc. is focused on developing treatments for diseases that cause severe pain. The Company operates through three segments Biotechnology, Recycling, and Technology. The Biotechnology segment is focused on the development of new solutions for ending the opioid epidemic ranging from digital technologies to educational advocacy. The recycling segment includes all fees charged and costs incurred for collecting, recycling, and installing appliances for utilities and other customers. The recycling segment also includes byproduct revenue, which is primarily generated through the recycling of appliances. The technology segment designs wireless modules to connect devices to the Mobile Internet of Things (IoT) which contain location-based service (LBS) capabilities and can interface to external sensors to allow them to communicate both sensor status and position information.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.